Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Zazueta A, Valenzuela-Pérez L, Ortiz-López N, Pinto-León A, Torres V, Guiñez D, Aliaga N, Merino P, Sandoval A, Covarrubias N, Pérez de Arce E, Cattaneo M, Urzúa A, Roblero JP, Poniachik J, Gotteland M, Magne F, Beltrán CJ. Zazueta A, et al. Among authors: roblero jp. Int J Mol Sci. 2024 Apr 16;25(8):4387. doi: 10.3390/ijms25084387. Int J Mol Sci. 2024. PMID: 38673972 Free PMC article.
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Méndez-Sánchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Arab JP, et al. Among authors: roblero jp. Ann Hepatol. 2019 May-Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Ann Hepatol. 2019. PMID: 31053546 Free article. Review.
A new definition for non-alcoholic fatty liver disease.
Poniachik J, Roblero JP, Urzúa A, Cattaneo M. Poniachik J, et al. Among authors: roblero jp. J Hepatol. 2021 Apr;74(4):982-983. doi: 10.1016/j.jhep.2020.09.002. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340572 No abstract available.
The immune response as a therapeutic target in non-alcoholic fatty liver disease.
Ortiz-López N, Fuenzalida C, Dufeu MS, Pinto-León A, Escobar A, Poniachik J, Roblero JP, Valenzuela-Pérez L, Beltrán CJ. Ortiz-López N, et al. Among authors: roblero jp. Front Immunol. 2022 Oct 10;13:954869. doi: 10.3389/fimmu.2022.954869. eCollection 2022. Front Immunol. 2022. PMID: 36300120 Free PMC article. Review.
Effect of acute on chronic liver failure over post-transplant survival.
Benítez C, Arnold J, Cambindo V, Schoenfeldt F, Cancino A, Ibáñez S, Grandy C, Hunfan P, González J, Guerra C, Godoy E, Araneda V, Mollo C, Poniachik J, Urzúa A, Cattaneo M, Roblero JP, Oppenheimer I, Pizarro V. Benítez C, et al. Among authors: roblero jp. Ann Hepatol. 2023 Sep-Oct;28(5):101128. doi: 10.1016/j.aohep.2023.101128. Epub 2023 Jun 17. Ann Hepatol. 2023. PMID: 37331597 Free article.
[Primary biliary cholangitis. Experience in 179 patients].
Ramírez F, Urzúa Á, Roblero JP, Cattaneo M, Hurtado C, Poniachik J. Ramírez F, et al. Among authors: roblero jp. Rev Med Chil. 2022 Jul;150(7):889-895. doi: 10.4067/s0034-98872022000700889. Rev Med Chil. 2022. PMID: 37906822 Free article. Spanish.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
36 results